• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EMBO J . Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein

tetano

Editor, Senior Moderator
EMBO J


. 2022 May 4;e108306.
doi: 10.15252/embj.2021108306. Online ahead of print.
Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein


Antoine Guillon[SUP] 1 2 3 [/SUP], Deborah Brea-Diakite[SUP] 1 2 [/SUP], Adeline Cezard[SUP] 1 2 [/SUP], Alan Wacquiez[SUP] 1 2 [/SUP], Thomas Baranek[SUP] 1 2 [/SUP], Jérôme Bourgeais[SUP] 2 4 5 [/SUP], Frédéric Picou[SUP] 2 4 5 [/SUP], Virginie Vasseur[SUP] 1 2 [/SUP], Léa Meyer[SUP] 6 [/SUP], Christophe Chevalier[SUP] 6 [/SUP], Adrien Auvet[SUP] 1 2 3 [/SUP], José M Carballido[SUP] 7 [/SUP], Lydie Nadal Desbarats[SUP] 8 [/SUP], Florent Dingli[SUP] 9 [/SUP], Andrei Turtoi[SUP] 10 11 12 [/SUP], Audrey Le Gouellec[SUP] 13 [/SUP], Florence Fauvelle[SUP] 14 15 [/SUP], Amélie Donchet[SUP] 16 [/SUP], Thibaut Crépin[SUP] 16 [/SUP], Pieter S Hiemstra[SUP] 17 [/SUP], Christophe Paget[SUP] 1 2 [/SUP], Damarys Loew[SUP] 9 [/SUP], Olivier Herault[SUP] 2 4 5 [/SUP], Nadia Naffakh[SUP] 18 [/SUP], Ronan Le Goffic[SUP] 6 [/SUP], Mustapha Si-Tahar[SUP] 1 2 [/SUP]



Affiliations

Abstract

Influenza virus infection causes considerable morbidity and mortality, but current therapies have limited efficacy. We hypothesized that investigating the metabolic signaling during infection may help to design innovative antiviral approaches. Using bronchoalveolar lavages of infected mice, we here demonstrate that influenza virus induces a major reprogramming of lung metabolism. We focused on mitochondria-derived succinate that accumulated both in the respiratory fluids of virus-challenged mice and of patients with influenza pneumonia. Notably, succinate displays a potent antiviral activity in vitro as it inhibits the multiplication of influenza A/H1N1 and A/H3N2 strains and strongly decreases virus-triggered metabolic perturbations and inflammatory responses. Moreover, mice receiving succinate intranasally showed reduced viral loads in lungs and increased survival compared to control animals. The antiviral mechanism involves a succinate-dependent posttranslational modification, that is, succinylation, of the viral nucleoprotein at the highly conserved K87 residue. Succinylation of viral nucleoprotein altered its electrostatic interactions with viral RNA and further impaired the trafficking of viral ribonucleoprotein complexes. The finding that succinate efficiently disrupts the influenza replication cycle opens up new avenues for improved treatment of influenza pneumonia.

Keywords: antiviral; influenza; metabokine; signaling; virus.
 
Back
Top Bottom